慢性便秘肠道微生态临床应用中国专家共识(2024版)

Chinese expert consensus on the clinical diagnosis and treatment of gut microecology in chronic constipation(2024 edition)

慢性便秘是常见的胃肠疾病之一,发病率呈逐年上升趋势,严重影响着人民的生活质量。近年来,慢性便秘的基础与临床研究取得了一定的进展,尤其是肠道微生态治疗方法日益受到关注。为此,在中华医学会肠外肠内营养学分会、中国人体健康科技促进会肠道微生态与肠菌移植专业委员会和上海市预防医学会肠道微生态专业委员会的倡议下,组织国内相关领域专家成立了《慢性便秘肠道微生态临床应用中国专家共识(2024版)》编写委员会,围绕肠道菌群紊乱、肠道微生态治疗的适应证和肠菌移植的方案,通过检索国内外文献、汇集专家们的临床经验,提出了16条推荐意见,旨在规范慢性便秘的肠道微生态临床应用。

Chronic constipation is one of the common gastrointestinal disorders,with an incidence rate that is gradually increasing yearly and becoming an important chronic disease that affects people's health and quality of life.In recent years,significant progress has been made in the basic and clinical research of chronic constipation,especially the gut microbiota therapy methods have received increasing attention.Therefore,under the initiative of the Parenteral and Enteral Nutrition Branch of the Chinese Medical Association,Chinese Society for the Promotion of Human Health Science and Technology,and Committee on Gut Microecology and Fecal Microbiota Transplantation,experts from relevant fields in China have been organized to establish the"Chinese Expert Consensus on the Clinical Diagnosis and Treatment of Gut Microecology in Chronic Constipation(2024 Edition)"committee.Focusing on the dysbiosis of gut microbiota,the indications for gut microbiota therapy,and the protocols for fecal microbiota transplantation,16 consensus opinions were proposed based on the review of domestic and international literature and the clinical experience of experts,aiming to standardize the clinical application of gut microbiota in chronic constipation.